Mercado de Polymarket
Prediction market
Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.
Proximo
- Probabilidad
- 44%
- Liquidez
- $25.62K
- Mejor compra
- 1%
- Mejor venta
- 99%
- Spread
- 98%
- Ultimo trade
- 44%
Outcomes
Resultados del mercado
Precio en vivo
Precio y liquidez
Compra, venta, punto medio, spread y profundidad actuales para este resultado.
- Mejor compra
- 1%
- Mejor venta
- 99%
- Punto medio
- 50%
- Spread
- 98%
- Ultimo trade
- 44%
- Profundidad
- 24.602,59 / 1020,45
Historial de precios
Esperando historial de precios
Historial no disponible
Compras
| Precio | Tamano |
|---|---|
| 1% | 18,000 |
| 2% | 19.59 |
| 10% | 2,700 |
| 11% | 600 |
| 12% | 27.44 |
| 20% | 1,350 |
| 22% | 900 |
| 23% | 350 |
Ventas
| Precio | Tamano |
|---|---|
| 99% | 9,48 |
| 96% | 500 |
| 95% | 255,94 |
| 92% | 108 |
| 86% | 100 |
| 80% | 10 |
| 73% | 37,03 |
Trades
Trades recientes
Latest visible trades for this market.
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 56% 25 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 53% 50 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?No 47% 0.36 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?No 47% 7.8 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?No 47% 10.21 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?No 18% 10.21 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 54.2% 21.31 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 52% 19.94 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 52% 57 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 52% 19.94 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 51% 5.06 shares
- Will Johnson & Johnson (JNJ) Q2 MedTech revenue be above $9B?Yes 62% 5.27 shares